French Pharmaceuticals & Biotech Top Stock Picks from Analysts

Valneva

Market Cap: €470.7m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Inventiva

Market Cap: €420.4m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of MASH and other diseases in France, the United States, and Internationally.

ABIVAX Société Anonyme

Market Cap: €416.1m

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Genfit

Market Cap: €198.3m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Innate Pharma

Market Cap: €179.2m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

Nanobiotix

Market Cap: €176.6m

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

OSE Immunotherapeutics

Market Cap: €137.5m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Sensorion

Market Cap: €111.2m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Cellectis

Market Cap: €96.7m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

MaaT Pharma

Market Cap: €90.7m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

AB Science

Market Cap: €76.5m

A clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France.

ABIONYX Pharma

Market Cap: €45.4m

A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.

GenSight Biologics

Market Cap: €28.2m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

Advicenne

Market Cap: €22.2m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.

Valbiotis

Market Cap: €19.6m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Aelis Farma

Market Cap: €16.1m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Nicox

Market Cap: €15.9m

Operates as an ophthalmology company in France and internationally.

NFL Biosciences

Market Cap: €15.2m

A biotechnology company, engages in the development of natural addiction withdrawal solutions for smokers.

Predilife

Market Cap: €13.8m

Develops and sells medical techniques and mathematical models.

Theranexus Société Anonyme

Market Cap: €8.5m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

TME Pharma

Market Cap: €7.9m

A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.

Oncodesign Precision Medicine Société anonyme

Market Cap: €5.7m

A biopharmaceutical company, engages in the precision medicine business.

PHAXIAM Therapeutics

Market Cap: €2.0m

A biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States.